Page 52 - Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

4. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 21. Lucet JC, Bailly MP, Bedos JP, Wolff M, Gachot B, Vachon F. Septic shock
1992;15(2):211-22. https://doi.org/10.1093/clinids/15.2.211 due to toxoplasmosis in patients ınfected with the human ımmuno-
5. Grant IH, Gold JW, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplas- deficiency virus. CHEST 1993;104:1054-8. https://doi.org/10.1378/
ma gondii serology in HIV-infected patients: The development of central chest.104.4.1054
nervous system toxoplasmosis in AIDS. AIDS 1990;4(6):519-21. https:// 22. Hofman P, Bernard E, Michiels JF, Thyss A, le Fichoux Y, Loubière R. Ex-
doi.org/10.1097/00002030-199006000-00004 tracerebral toxoplasmosis in the acquired immunodeficiency syndrome
(AIDS). Pathology-Research and Practice 1993;189:894-901. https://doi.
6. Blaser MJ, Cohn DL. Opportunistic infections in patients with AIDS: Clues
to the epidemiology of AIDS and the relative virulence of pathogens. Rev org/10.1016/S0344-0338(11)81101-5
Infect Dis 1986;8:21-30. https://doi.org/10.1093/clinids/8.1.21 23. National Institutes of Health. Guidelines for the Prevention and Treat-
ment of Opportunistic Infections in Adults and Adolescents with HIV:
7. Leport C, Chêne G, Morlat P, Luft BJ, Rousseau F, Pueyo S, et al. Pyrimeth-
amine for primary prophylaxis of toxoplasmic encephalitis in patients Toxoplasma gondii Encephalitis. Erişim adresi: https://clinicalinfo.hiv.
with human immunodeficiency virus infection: a double-blind, rand- gov/en/guidelines/adult-and-adolescent-opportunistic-infection/toxo-
omized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de plasma-gondii-encephalitis?view=full (Erişim tarihi: 02.01.2022).
Recherche sur le SIDA. AIDS Clinical Trial Gr. J Infect Dis 1996;173:91-7. 24. Cohn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of
https://doi.org/10.1093/infdis/173.1.91 the policy of empiric treatment of suspected Toxoplasma encephalitis
in patients with the acquired immunodeficiency syndrome. Am J Med
8. Abgrall S, Rabaud C, Costagliola D. Incidence and risk factors for toxo- 1989;86:521-7. https://doi.org/10.1016/0002-9343(89)90378-1
plasmic encephalitis in human immunodeficiency virus-infected pa-
tients before and during the highly active antiretroviral therapy era. Clin 25. Andrews BT, Kenefick TP. Neurosurgical management of the acquired im-
Infect Dis 2001;33(10):1747-55. https://doi.org/10.1086/322622 munodeficiency syndrome. An update. West J Med 1993;158(3):249-53.
9. Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, et al. 26. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS. Toxoplasmic en-
Prevalence and predictors of Toxoplasma seropositivity in women with cephalitis in patients with acquired immune deficiency syndrome. JAMA
and at risk for human immunodeficiency virus infection. Clin Infect Dis 1984;252:913-7. https://doi.org/10.1001/jama.1984.03350070031018
2002;35:1414-7. https://doi.org/10.1086/344462 27. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, et
al. Toxoplasmic encephalitis in patients with the acquired immuno-
10. Wallace MR, Rossetti RJ, Olson PE. Cats and Toxoplasmosis risk in
HIV-infected adults. JAMA 1993;269:76-7. https://doi.org/10.1001/ deficiency syndrome. Members of the ACTG 077p/ANRS 009 Study
Team. N Engl J Med 1993;329:995-1000. https://doi.org/10.1056/
jama.1993.03500010086037
NEJM199309303291403
11. Levy RM, Janssen RS, Bush TJ, Rosenblum ML. Neuroepidemiology of
acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 28. Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE. The
1988;1:31. efficacy and clinical impact of brain imaging in neurologically symp-
tomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune
12. Jones JL, Roberts JM. Toxoplasmosis Hospitalizations in the United Defic Syndr (1988) 1990;3(5):461-71. https://doi.org/10.1097/00126334-
States, 2008, and Trends, 1993-2008. Clin Infect Dis 2012;54:e58-61. 199005000-00001
https://doi.org/10.1093/cid/cir990
29. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish
13. Belanger F, Derouin F, Grangeot-Keros L, Meyer L. Incidence and risk fac- intracranial lesions and to define the need for biopsy in AIDS pa-
tors of toxoplasmosis in a cohort of human ımmunodeficiency virus-in- tients. J Neurosurg 1990 Nov;73(5):720-4. https://doi.org/10.3171/
fected patients: 1988-1995. Clin Infect Dis 1999;28:575-81. https://doi. jns.1990.73.5.0720
org/10.1086/515147
30. Miller RF, Hall-Craggs MA, Costa DC, Brink NS, Scaravilli F, Lucas SB, et
14. Rabaud C, May T, Amiel C, Katlama C, Leport C, Ambroise-Thom- al. Magnetic resonance imaging, thallium-201 SPET scanning, and
as P, et al. Extracerebral toxoplasmosis in patients infected with HIV. laboratory analyses for discrimination of cerebral lymphoma and tox-
A French National Survey. Medicine 1994;73:306-14. https://doi. oplasmosis in AIDS. Se Sex Transm Infect 1998;74:258-64. https://doi.
org/10.1097/00005792-199411000-00004 org/10.1136/sti.74.4.258
15. Pugin J, Vanhems P, Hirschel B, Chave JP, Flepp M. Extreme elevations of 31. Skiest DJ, Erdman W, Chang WE, Oz OK, Ware A, Fleckenstein J. SPECT
serum lactic dehydrogenase differentiating pulmonary toxoplasmosis thallium-201 combined with Toxoplasma serology for the presumptive
from Pneumocystis pneumonia. N Engl J Med 1992;326:1226-7. https:// diagnosis of focal central nervous system mass lesions in patients with
doi.org/10.1056/NEJM199204303261815 AIDS. J Infect 2000;40:274-81. https://doi.org/10.1053/jinf.2000.0664
16. Butt AA, Michaels S, Kissinger P. The association of serum lactate dehy- 32. Westwood TD, Hogan C, Julyan PJ, Coutts G, Bonington S, Carrington
drogenase level with selected opportunistic infections and HIV progres- B, et al. Utility of FDG-PETCT and magnetic resonance spectroscopy in
sion. Int J Infect Dis 2002;6(3):178-81. https://doi.org/10.1016/S1201- differentiating between cerebral lymphoma and non-malignant CNS le-
9712(02)90107-4 sions in HIV-infected patients. Eur J Radiol 2013;82(8):e374-9. https://doi.
org/10.1016/j.ejrad.2013.03.008
17. Rabaud C, May T, Lucet JC, Leport C, Ambroise-Thomas P, Canton P.
Pulmonary toxoplasmosis in patients infected with human immunode- 33. Lorberboym M, Wallach F, Estok L, Mosesson RE, Sacher M, Kim CK, et al.
ficiency virus: A French National Survey. Clin Infect Dis 1996;23(6):1249- Thallium-201 retention in focal intracranial lesions for differential diag-
54. https://doi.org/10.1093/clinids/23.6.1249 nosis of primary lymphoma and nonmalignant lesions in AIDS patients.
J Nucl Med 1998;39.
18. Moshfeghi DM, Dodds EM, Couto CA, Santos CI, Nicholson DH, Lowder
CY, et al. Diagnostic approaches to severe, atypical toxoplasmosis mim- 34. O’Doherty M, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scan-
icking acute retinal necrosis. Ophthalmol 2004;111:716-25. https://doi. ning and the human ımmunodeficiency virus-positive patient. J Nucl
org/10.1016/j.ophtha.2003.07.004 Med 1997;38.
19. Montoya JG, Remington JS. Toxoplasma gondii. In: Principles and Prac- 35. Conley FK, Jenkins KA, Remington JS. Toxoplasma gondii infection of the
tice of Infectious Diseases, 5th Edition, Mandell GL, Bennett JE, Dolin R central nervous system. Use of the peroxidase-antiperoxidase method
(Eds), Churchill Livingstone, Philadelphia 2000. p.2858. to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue
sections. Hum Pathol 1981;12:690-8. https://doi.org/10.1016/S0046-
20. Vyas R, Ebright JR. Toxoplasmosis of the Spinal Cord in a Patient with 8177(81)80170-0
AIDS: Case Report and Review. Clin Infect Dis 1996;23:1061-5. https://
doi.org/10.1093/clinids/23.5.1061

43